[HTML][HTML] New microbiological aspects of fosfomycin
M Díez-Aguilar, R Cantón - Revista Española de Quimioterapia, 2019 - ncbi.nlm.nih.gov
The discovery of fosfomycin more than 40 years ago was an important milestone in antibiotic
therapy. The antibiotic's usefulness, alone or in combination, for treating infections caused …
therapy. The antibiotic's usefulness, alone or in combination, for treating infections caused …
Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections
Human Pseudomonas infections have high morbidity and mortality rates. Pseudomonas
bacteria can cause sepsis or septic shock; they produce biofilm and commonly exhibit a …
bacteria can cause sepsis or septic shock; they produce biofilm and commonly exhibit a …
Performance of four fosfomycin susceptibility testing methods against an international collection of clinical Pseudomonas aeruginosa isolates
EC Smith, HV Brigman, JC Anderson… - Journal of clinical …, 2020 - Am Soc Microbiol
Fosfomycin has been shown to have a wide spectrum of activity against multidrug-resistant
Gram-negative bacteria; however, breakpoints have been established only for Escherichia …
Gram-negative bacteria; however, breakpoints have been established only for Escherichia …
The application of hollow fiber cartridge in biomedicine
Y Hou, K Mi, L Sun, K Zhou, L Wang, L Zhang, Z Liu… - Pharmaceutics, 2022 - mdpi.com
The hollow fiber cartridge has the advantages of good semi-permeability, high surface area
to volume ratio, convenient operation, and so on. Its application in chemical analysis, drug in …
to volume ratio, convenient operation, and so on. Its application in chemical analysis, drug in …
Pharmacokinetic/pharmacodynamic integration of amphenmulin: a novel pleuromutilin derivative against Mycoplasma gallisepticum
W Wang, J Yu, X Ji, X Xia, H Ding - Microbiology Spectrum, 2024 - Am Soc Microbiol
Amphenmulin is a novel pleuromutilin derivative with great anti-mycoplasma potential. The
present study evaluated the action characteristics of amphenmulin against Mycoplasma …
present study evaluated the action characteristics of amphenmulin against Mycoplasma …
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trial
C Dorn, D Petroff, N Neumann, A Kratzer… - Journal of …, 2019 - academic.oup.com
Objectives To assess the pharmacokinetics and tissue penetration of fosfomycin in obese
and non-obese surgical patients. Methods Fifteen obese patients undergoing bariatric …
and non-obese surgical patients. Methods Fifteen obese patients undergoing bariatric …
Dose Optimization of Combined Linezolid and Fosfomycin against Enterococcus by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model
J Mao, T Li, N Zhang, S Wang, Y Li, Y Peng… - Microbiology …, 2021 - Am Soc Microbiol
The rapid spread of antibiotic resistance among Enterococcus has prompted considerable
interest in determining the dosage regimen of linezolid combined with fosfomycin. A …
interest in determining the dosage regimen of linezolid combined with fosfomycin. A …
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa
LM Avery, CA Sutherland… - Journal of Medical …, 2019 - microbiologyresearch.org
Purpose. We assessed the synergistic potential of fosfomycin and parenteral antibiotics
among carbapenem-resistant Pseudomonas aeruginosa (CRP). Methodology. Minimum …
among carbapenem-resistant Pseudomonas aeruginosa (CRP). Methodology. Minimum …
Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?
Introduction: The intravenous (IV) formulation of fosfomycin has been re-introduced in
clinical practice mainly to overcome treatment failures against multidrug-resistant (MDR) …
clinical practice mainly to overcome treatment failures against multidrug-resistant (MDR) …
Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants
X Xia, L Yang, Y Ling, J Yu, H Ding - Frontiers in Veterinary Science, 2022 - frontiersin.org
Macrolides are widely used in diseases caused by Mycoplasma spp. The new semi-
synthetic macrolide antibiotic tulathromycin is currently in wide use for the treatment of …
synthetic macrolide antibiotic tulathromycin is currently in wide use for the treatment of …